E48K (p.Glu48Lys) variant of GCK (Hexokinase-4)

E48K (p.Glu48Lys) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.60 / 1. The record also includes population frequency data, published literature, and structural context.

E48K (p.Glu48Lys) variant details